Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech regulatory approval

Qure.ai Aira Wins Class IIb CE Certification

Analysis based on 8 articles · First reported Sep 17, 2026 · Last updated Sep 18, 2026

Sentiment
15
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The CE certification strengthens Qure.ai's competitive position in regulated medical AI and could accelerate procurement by health ministries and institutional funders, potentially boosting demand for AI-powered clinical decision support in emerging markets. Broader market impact is limited given Qure.ai is privately held, though the milestone reinforces the growth narrative for healthcare AI and medical device software sectors.

healthcare medical devices artificial intelligence

Qure.ai announced that its Aira clinical decision support system (CDSS) received Class IIb CE certification under the EU Medical Device Regulation (MDR). Aira is described as the first AI-powered CDSS to combine documentation, workflow automation, and analysis of patient EHR data with clinical decision-making under a single CE mark. The certification, announced on September 17-18, 2026, comes a year after Aira's launch at the World Health Assembly in 2025. Class IIb is one of the EU's highest regulatory scrutiny levels for software supporting critical patient decisions, giving health ministries, providers, and funders an independently assessed foundation for evaluation and procurement. In its first year, Aira scaled to ten live pilot sites across Nigeria, Kenya, Mozambique, Solomon Islands, and Bangladesh, reaching thousands of patients. Deployments include ART-center support with the Catholic Caritas Foundation of Nigeria, integration into Mozambique's AloVida national platform with VillageReach, digitization of paper-based reporting in the Solomon Islands in support of WHO's Western Pacific Regional Office, and deployment in Bangladesh with Endless Health. In Kenya, Aira reportedly cut protocol-driven documentation time by 32% with a 98% completion rate, while in Nigeria the clinical-to-administrative time ratio improved by 67%. Qure.ai's broader portfolio spans 105+ countries with 26+ FDA-cleared findings and CE marking for 60+ indications. The company is now pursuing population-scale deployments with ministries of health and institutional funders.

95 Qure.ai received Class IIb CE certification European Union
60 Qure.ai launched Aira
50 Qure.ai scaled pilot sites
40 Qure.ai deployed Aira Catholic Caritas Foundation of Nigeria
40 Qure.ai deployed Aira Kenya
40 Qure.ai integrated Aira Mozambique
30 Qure.ai digitized health reporting Solomon Islands
30 Qure.ai deployed Aira Bangladesh
25 Qure.ai cut documentation time Kenya
25 Qure.ai improved clinical time ratio Nigeria
priv
Qure.ai is the central actor, receiving Class IIb CE certification for its Aira CDSS, which validates its clinical decision support within the EU's rigorous regulatory framework and supports population-scale deployment ambitions.
Importance 100.0 Sentiment 60.0
alliance
The European Union, through its Medical Device Regulation framework, granted Class IIb CE certification to Aira, providing the regulatory validation central to this event.
Importance 50.0 Sentiment 10.0
per
As co-founder and CEO of Qure.ai, Prashant publicly framed the certification as a milestone validating clinical decision support and advancing the company's mission to expand dependable clinical intelligence to resource-stretched settings.
Importance 40.0 Sentiment 50.0
cnt
Nigeria hosts Aira deployments supporting ART-center health workers with the Catholic Caritas Foundation of Nigeria and the Adamawa State HIV/AIDS program, where the clinical-to-administrative time ratio reportedly improved by 67%.
Importance 30.0 Sentiment 20.0
cnt
Kenya is a pilot deployment country where Aira reportedly cut protocol-driven documentation time by 32% with a 98% completion rate, deployed with local implementation partners and Ministry of Health departments.
Importance 30.0 Sentiment 20.0
cnt
Mozambique integrated Aira into its AloVida national platform run by the Ministry of Health (MISAU), with VillageReach as implementing partner and support from a Gates Foundation initiative.
Importance 25.0 Sentiment 15.0
cnt
The Solomon Islands saw Aira digitize paper-based health reporting in support of WHO's Western Pacific Regional Office national reporting work.
Importance 20.0 Sentiment 15.0
cnt
Bangladesh is a pilot deployment country where Aira is being deployed with the support of Endless Health.
Importance 20.0 Sentiment 15.0
ngo
The World Health Organization's Western Pacific Regional Office benefited from Aira digitizing paper-based health reporting in the Solomon Islands, and Aira was launched at the World Health Assembly in 2025.
Importance 20.0 Sentiment 10.0
ngo
The Gates Foundation supports a pandemic preparedness initiative under which Aira is integrated into Mozambique's AloVida platform.
Importance 20.0 Sentiment 10.0
ngo
The Catholic Caritas Foundation of Nigeria partners with Qure.ai to deliver Aira's structured data capture and guideline-based decision support to ART-center health workers in Enugu and Ebonyi.
Importance 20.0 Sentiment 10.0
cnt
The United States hosts Qure.ai's New York office and is the base of the FDA, whose clearances are cited among Qure.ai's regulatory credentials.
Importance 15.0 Sentiment 10.0
cnt
India is home to Qure.ai's Mumbai headquarters and regional office, benefiting from the company's strengthened regulatory standing and global expansion.
Importance 15.0 Sentiment 10.0
govactor
The United States — Food and Drug Administration's clearances are cited among Qure.ai's regulatory credentials, with 26+ FDA-cleared findings supporting the company's broader portfolio.
Importance 15.0 Sentiment 10.0
ngo
VillageReach serves as the implementing partner for Aira's integration into Mozambique's AloVida national platform.
Importance 15.0 Sentiment 10.0
+ 2 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.